John Theurer Cancer Center Presents 15th Annual Northern NJ Breast Cancer Conference

Published: Friday, Mar 09, 2018

February 1, 2018 ― Hackensack, NJ ― Hackensack Meridian Health John Theurer Cancer Center at Hackensack University Medical Center presents the 15th Annual Northern NJ Breast Cancer Conference – a review of the 2017 San Antonio Breast Cancer Symposium, on Friday, February 23 from 7:00 a.m. - 3:15 p.m.

Date

Friday, Feb. 23, 2018

7 a.m. to 3:15 p.m.

Location

John Theurer Cancer Center at Hackensack University Medical Center

1st Floor Conference Room

92 Second Street, Hackensack, NJ

Program Goal

This program, based on data presented at the San Antonio Breast Cancer Symposium 2017, is designed to provide a review of state of the art information on experimental biology, etiology, prevention, diagnosis and therapy of breast cancer/ pre-malignant breast disease to an audience of academic and private physicians and researchers involved in medical, surgical, GYN and radiation therapy, as well as other appropriate health care professionals.

Course Director

Stanley E. Waintraub, M.D., F.A.C.P.

Breast Cancer Division Co-Chief, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ

Agenda

Breast Cancer and Less Surgery

Freya Schnabel, M.D.

Professor of Surgery NYU Langone Medical Center, New York, NY

Radiation Therapy: Deciding Who Does Not Need It

Lawrence J. Solin, M.D., FACR

Chairman, Radiation Oncology, Albert Einstein Medical Center Philadelphia, PA

The Role of Neoadjuvant Therapy in Clinically Node Positive Disease

Claudine Isaacs, M.D.

Co-Director, Breast Cancer Division, MedStar Georgetown University, Washington, D.C.

Metastic Breast Cancer: Anti Estrogens vs. Chemotherapy

Mary Elizabeth Cianfrocca, D.O.

Director, Breast Cancer Program, Banner MD Anderson Cancer Center Phoenix, AZ

The Role of Immunotherapy in Triple Negative Breast Cancer

Adam Brufsky, M.D., Ph.D.

Professor of Medicine University of Pittsburgh, Pittsburgh, PA

Hormonal Adjuvant Therapy Of Breast Cancer: The Role of CDK 4/6 Inhibitors

Harold Harvey, M.D.

Professor of Medicine, Milton S. Hershey Medical Center, Hershey, PA

Precision Medicine 2018: The Role of NGS on Uncirculating Free DNA

Brian Leyland-Jones, M.D., Ph.D.

Vice President, Avera Cancer Institute for Precision Oncology University of South Dakota, Sioux Falls, SD

Genomic Analysis in Early Stage Breast Cancer: Oncotype in Node Positive Breast Cancer

Andrew Seidman, M.D.

Associate Chair, Breast Medicine, Memorial Sloan Kettering Cancer Center New York, NY

Who Should Attend

Medical oncologists, breast surgeons, radiation oncologists, gynecologists, advanced practice providers, nurses, and other health care providers with an interest in the management of patients with breast cancer should attend this course.

Registration

To register for this event or if you have any questions, please contact Leonor Down at 551-996-5914 or Leonor.Down@hackensackmeridian.org

Registration fee is complementary. This activity has been approved for AMA PRA Category 1 Credit™

ACCREDITATION STATEMENT: Hackensack University Medical Center is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™: Choosing Therapies for Patients with EGFR-mutant Lung Cancers: More Options... More Decisions... Better OutcomesApr 27, 20182.0
Community Practice Connections™: 21st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and MyelomaApr 27, 20182.0
Publication Bottom Border
Border Publication
x